|
1
|
Field MG and Harbour JW: Recent
developments in prognostic and predictive testing in uveal
melanoma. Curr Opin Ophthalmol. 25:234–239. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schoenfield L: Uveal melanoma: A
pathologist's perspective and review of translational developments.
Adv Anat Pathol. 21:138–143. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eschelman DJ, Gonsalves CF and Sato T:
Transhepatic therapies for metastatic uveal melanoma. Semin
Intervent Radiol. 30:39–48. 2013. View Article : Google Scholar :
|
|
4
|
Rashid AB and Grossniklaus HE: Clinical,
pathologic, and imaging features and biological markers of uveal
melanoma. Methods Mol Biol. 1102:397–425. 2014. View Article : Google Scholar
|
|
5
|
Werdich XQ, Jakobiec FA, Singh AD and Kim
IK: A review of advanced genetic testing for clinical
prognostication in uveal melanoma. Semin Ophthalmol. 28:361–371.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yan X, Xu H and Yan Z: Functional
perspective and implications of gene expression by noncoding RNAs.
Cancer Transl Med. 1:137–152. 2015. View Article : Google Scholar
|
|
7
|
Chen Y, Zhao H, Tan Z, Zhang C and Fu X:
Bottleneck limitations for microRNA-based therapeutics from bench
to the bedside. Pharmazie. 70:147–154. 2015.PubMed/NCBI
|
|
8
|
Mansoori B, Mohammadi A, Shirjang S and
Baradaran B: Micro-RNAs: The new potential biomarkers in cancer
diagnosis, prognosis and cancer therapy. Cell Mol Biol
(Noisy-le-grand). 61:1–10. 2015.
|
|
9
|
Hata A and Lieberman J: Dysregulation of
microRNA biogenesis and gene silencing in cancer. Sci Signal.
8:re32015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shen J and Hung MC: Signaling-mediated
regulation of MicroRNA processing. Cancer Res. 75:783–791. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dong F and Lou D: MicroRNA-34b/c
suppresses uveal melanoma cell proliferation and migration through
multiple targets. Mol Vis. 18:537–546. 2012.PubMed/NCBI
|
|
12
|
Liu N, Sun Q, Chen J, Li J, Zeng Y, Zhai
S, Li P, Wang B and Wang X: MicroRNA-9 suppresses uveal melanoma
cell migration and invasion through the NF-κB1 pathway. Oncol Rep.
28:961–968. 2012.PubMed/NCBI
|
|
13
|
Yan D, Dong XD, Chen X, Yao S, Wang L,
Wang J, Wang C, Hu DN, Qu J and Tu L: Role of microRNA-182 in
posterior uveal melanoma: Regulation of tumor development through
MITF, BCL2 and cyclin D2. PLoS One. 7:e409672012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ventura A, Young AG, Winslow MM, Lintault
L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone
JR, et al: Targeted deletion reveals essential and overlapping
functions of the miR-17 through 92 family of miRNA clusters. Cell.
132:875–886. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Z, Wang B, Shi Y, Xu C, Xiao HL, Ma
LN, Xu SL, Yang L, Wang QL, Dang WQ, et al: Oncogenic miR-20a and
miR-106a enhance the invasiveness of human glioma stem cells by
directly targeting TIMP-2. Oncogene. 34:1407–1419. 2015. View Article : Google Scholar
|
|
16
|
Xiong Y, Zhang L and Kebebew E: MiR-20a is
upregulated in anaplastic thyroid cancer and targets LIMK1. PLoS
One. 9:e961032014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li X, Zhang Z, Yu M, Li L, Du G, Xiao W
and Yang H: Involvement of miR-20a in promoting gastric cancer
progression by targeting early growth response 2 (EGR2). Int J Mol
Sci. 14:16226–16239. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et
al: MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao S, Yao D, Chen J, Ding N and Ren F:
MiR-20a promotes cervical cancer proliferation and metastasis in
vitro and in vivo. PLoS One. 10:e01209052015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qiang XF, Zhang ZW, Liu Q, Sun N, Pan LL,
Shen J, Li T, Yun C, Li H and Shi LH: miR-20a promotes prostate
cancer invasion and migration through targeting ABL2. J Cell
Biochem. 115:1269–1276. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu Z, Wang C, Wang M, Li Z, Casimiro MC,
Liu M, Wu K, Whittle J, Ju X, Hyslop T, et al: A cyclin D1/microRNA
17/20 regulatory feedback loop in control of breast cancer cell
proliferation. J Cell Biol. 182:509–517. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Y, Zheng L, Ding Y, Li Q, Wang R,
Liu T, Sun Q, Yang H, Peng S, Wang W and Chen L: MiR-20a induces
cell radioresistance by activating the PTEN/PI3K/Akt signaling
pathway in hepatocellular carcinoma. Int J Radiat Oncol Biol Phys.
92:1132–1140. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hong TH and Park IY: MicroRNA expression
profiling of diagnostic needle aspirates from surgical pancreatic
cancer specimens. Ann Surg Treat Res. 87:290–297. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Achberger S, Aldrich W, Tubbs R, Crabb JW,
Singh AD and Triozzi PL: Circulating immune cell and microRNA in
patients with uveal melanoma developing metastatic disease. Mol
Immunol. 58:182–186. 2014. View Article : Google Scholar :
|
|
25
|
Puri KS, Suresh KR, Gogtay NJ and Thatte
UM: Declaration of Helsinki, 2008: Implications for stakeholders in
research. J Postgrad Med. 55:131–134. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hsu SD, Tseng YT, Shrestha S, Lin YL,
Khaleel A, Chou CH, Chu CF, Huang HY, Lin CM and Ho SY: miRTarBase
update 2014: An information resource for experimentally validated
miRNA-target interactions. Nucleic Acids Res. 42(Database Issue):
D78–D85. 2014. View Article : Google Scholar :
|
|
27
|
Wixon J and Kell D: The Kyoto encyclopedia
of genes and genomes-KEGG. Yeast. 17:48–55. 2000.PubMed/NCBI
|
|
28
|
Qureshi R and Sacan A: A novel method for
the normalization of microRNA RT-PCR data. BMC Med Genomics.
6(Suppl 1): S142013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Z, Yu X, Shen J and Jiang Y: MicroRNA
dysregulation in uveal melanoma: A new player enters the game.
Oncotarget. 6:4562–4568. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Eldh M, Olofsson Bagge R, Lässer C,
Svanvik J, Sjöstrand M, Mattsson J, Lindnér P, Choi DS, Gho YS and
Lötvall J: MicroRNA in exosomes isolated directly from the liver
circulation in patients with metastatic uveal melanoma. BMC Cancer.
14:9622014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Grillari J, Hackl M and Grillari-Voglauer
R: miR-17-92 cluster: Ups and downs in cancer and aging.
Biogerontology. 11:501–506. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xie R, Lin X, Du T, Xu K, Shen H, Wei F,
Hao W, Lin T, Lin X, Qin Y, et al: Targeted disruption of miR-17-92
impairs mouse spermatogenesis by activating mTOR signaling pathway.
Medicine (Baltimore). 95:e27132016. View Article : Google Scholar
|
|
33
|
Li L, Shi JY, Zhu GQ and Shi B: MiR-17-92
cluster regulates cell proliferation and collagen synthesis by
targeting TGFB pathway in mouse palatal mesenchymal cells. J Cell
Biochem. 113:1235–1244. 2012. View Article : Google Scholar
|
|
34
|
Zhang GJ, Li Y, Zhou H, Xiao HX and Zhou
T: miR-20a is an independent prognostic factor in colorectal cancer
and is involved in cell metastasis. Mol Med Rep. 10:283–291.
2014.PubMed/NCBI
|
|
35
|
Zhuo W, Ge W, Meng G, Jia S, Zhou X and
Liu J: MicroRNA-20a promotes the proliferation and cell cycle of
human osteosarcoma cells by suppressing early growth response 2
expression. Mol Med Rep. 12:4989–4994. 2015.PubMed/NCBI
|
|
36
|
Wei W, Hou J, Alder O, Ye X, Lee S, Cullum
R, Chu A, Zhao Y, Warner SM, Knight DA, et al: Genome-wide microRNA
and messenger RNA profiling in rodent liver development implicates
mir302b and mir20a in repressing transforming growth factor-beta
signaling. Hepatology. 57:2491–2501. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ristau J, Staffa J, Schrotz-King P, Gigic
B, Makar KW, Hoffmeister M, Brenner H, Ulrich A, Schneider M,
Ulrich CM and Habermann N: Suitability of circulating miRNAs as
potential prognostic markers in colorectal cancer. Cancer Epidemiol
Biomarkers Prev. 23:2632–2637. 2014. View Article : Google Scholar : PubMed/NCBI
|
